The company today reported that the agency issued a Form 483 with five observations following a preapproval and good manufacturing practices inspection last week. It didn’t say what product it is ...

Biocon Biologics has been positioning itself to become a global player in biosimilar drugs. Viatris, a longtime partner to Biocon, is charting a course for its future that does not include biosimilars ...

Biocon share price jumped over 4% to a fresh 52-week high on Thursday after reports stated that the company was evaluating an internal merger of its biosimilars arm, Biocon Biologics, with the parent ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

** European Medicines Agency on Thursday accepted Biocon and U.S. drugmaker Mylan's regulatory submission for proposed breast cancer drug Sign up here. ** The submission could lead to approval of the ...